Results for tag: "Ofatumumab"

Ofatumumab is a monoclonal antibody used to treat certain types of leukemia. It is used in combination with chemotherapy to treat chronic lymphocytic leukemia (CLL) and in combination with other drugs to treat relapsed or refractory CLL. It is also used to treat a type of leukemia called small lymphocytic lymphoma (SLL). Ofatumumab works by targeting a protein called CD20, which is found on the surface of certain types of cancer cells. This protein helps the cancer cells to grow and divide. By targeting this protein, ofatumumab can help to slow down the growth and spread of cancer cells. Ofatumumab is approved by the US Food and Drug Administration (FDA) for the treatment of CLL and SLL. It is also approved in Europe and other countries for the same indications. Some companies in the Ofatumumab market include Novartis, Gilead Sciences, and GlaxoSmithKline. Show Less Read more